Epidemiology, Virology, and Prevention
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 12179
Special Issue Editor
Interests: emerging virus; vaccine; arbovirus; animal model; viral attenuation
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit your manuscripts to this Special Issue, entitled "Epidemiology, Virology, and Prevention". Since the first vaccine was reported by Edward Jenner in the eighteenth century, many vaccines have been developed and used around the world. Many viral infectious diseases such as variola, yellow fever, measles, rubella, rotavirus disease, and polio, that once threatened humans, have been controlled by vaccines.
The aim of this Special Issue is to provide readers with present knowledge about the epidemiology, virology, and preventive methods of vaccine-preventable and emerging viral diseases. Areas of research in this field include the following: (1) epidemiology of viral diseases including vaccine-preventable diseases; (2) immune responses to vaccines; (3) vaccine development and efficacy evaluation of non-clinical phase and clinical phase; (4) vaccine immunology; (5) vaccine development against emerging viral diseases. Basic viral vaccine research, such as the generation of attenuated viruses and analyses of vaccine efficacy in model animals, is also welcome. Both original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Satoshi Taniguchi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- epidemiology
- viral immunity
- prevention
- immune response
- emerging virus
- animal model
- vaccine trial
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.